Article
Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Durvalumab plus BCG significantly improves DFS in NMIBC
Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025
Stent omission after ureteroscopy is safe, improves patient-reported outcomes
Intervention to increase fluid intake does not reduce recurrent stones